Search Results 381-390 of 17069 for pharmacogenetics
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
View faculty and staff of Mayo Clinic's Epigenetic Etiology of Human Disease Lab led by Keith D. Robertson, Ph.D.
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
Mayo Clinic's High-Dimensional Phenotyping Lab is a translational research & innovation lab that seeks to understand physiology at scale & deploy rigorous, ...
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers access to the Mayo PKD Clinical Database to study autosomal dominant polycystic kidney ...
The purpose of this study is to sequence patient germline and tumor samples, and nominate top neoantigen candidates using an in-house developed bioinformatics ...
The purpose of this study is to compare the effectiveness of temozolomide to selumetinib for the treatment of patients who have melanoma of the eye that has ...
The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is ...
This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!